IVERIC bio, Inc. (ISEE) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 222 transactions totaling $24.8M, demonstrating a bearish sentiment with -$23.6M in net insider flow. The most recent transaction on Jul 11, 2023 involved a transaction of 22,088 shares valued at $0.
No significant insider buying has been recorded for ISEE in the recent period.
No significant insider selling has been recorded for ISEE in the recent period.
Based on recent SEC filings, insider sentiment for ISEE is bearish with an Insider Alignment Score of 3/100 and a net flow of -$23.6M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at IVERIC bio, Inc. (ISEE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading ISEE stock, having executed 222 transactions in the past 90 days. The most active insider is Keith Westby (Executive), who has made 71 transactions totaling $11.8M.
Get notified when executives and directors at ISEE file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 11, 2023 | Bolte Axel | Executive | Disposition | 22,088 | $N/A | $0 | |
| Jul 11, 2023 | S. Gibney Anthony | Executive | Disposition | 40,291 | $N/A | $0 | |
| Jul 11, 2023 | Westby Keith | Executive | Disposition | 39,652 | $N/A | $0 | |
| Jul 11, 2023 | Henderson Jane | Executive | Disposition | 22,088 | $N/A | $0 | |
| Jul 11, 2023 | Dugel Pravin | Executive | Disposition | 203,035 | $N/A | $0 | |
| Jul 11, 2023 | Paul Simms Christopher | Executive | Disposition | 32,429 | $N/A | $0 | |
| Jul 11, 2023 | Sblendorio Glenn | Executive | Disposition | 239,275 | $N/A | $0 | |
| Jul 11, 2023 | W. Roberts Calvin | Executive | Disposition | 47,088 | $N/A | $0 | |
| Jul 11, 2023 | L. Graves Adrienne | Executive | Disposition | 22,088 | $N/A | $0 | |
| Jul 11, 2023 | Ann Miller Christine | Executive | Disposition | 13,075 | $N/A | $0 | |
| Jul 11, 2023 | Francis Carroll David | Executive | Disposition | 44,152 | $N/A | $0 | |
| Jul 11, 2023 | S. Blumenkranz Mark | Executive | Disposition | 32,088 | $N/A | $0 | |
| Jul 3, 2023 | Westby Keith | Executive | Sale | 20,000 | $39.45 | $789.0K | Large10b5-1 |
| Jul 3, 2023 | Westby Keith | Executive | Option Exercise | 20,000 | $2.94 | $58.8K | 10b5-1 |
| Jun 28, 2023 | S. Gibney Anthony | Executive | Gift | 2,500 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 85 | $24.2M | 91.6% |
Exercise(M) | 110 | $1.6M | 6.1% |
Purchase(P) | 5 | $624.3K | 2.4% |
Disposition(D) | 12 | $0 | 0.0% |
Gift(G) | 6 | $0 | 0.0% |
Other(J) | 4 | $0 | 0.0% |
Insider selling pressure at IVERIC bio, Inc. has increased, with 14 insiders executing 222 transactions across all time. Total sales of $24.2M significantly outpace purchases of $624.3K, resulting in a net outflow of $23.6M. However, 50% of these transactions are pre-scheduled 10b5-1 plans, often used for tax planning or diversification rather than signaling negative outlook.